Since mTOR plays important roles in regulating cancer cell growth, metabolism, and protein synthesis, the inhibition of this complex is regarded as another interesting pharmacological approach to reduce the effects of a constitutive PI3K/Akt activation in GBM (Table 2). This evidence concerns the gene AKT1 and glioblastoma.